-
Metal-Free Carbon Nanozymes for ALP Detection
2026-08-17
The reference study introduces metal-free carbon dots as nanozymes for a turn-on colorimetric assay of alkaline phosphatase activity. Its key advance is the kinetic identification of pyrophosphate as a noncompetitive inhibitor at a site distinct from the principal catalytic region, enabling sensitive ALP measurement without metal-based components.
-
Dibutyryl-cAMP, Sodium Salt for Brain Slice Assays
2026-08-17
Dibutyryl-cAMP, sodium salt provides a stable, cell-permeable way to perturb cAMP–PKA signaling in cultured cells and organotypic brain slices. This guide connects practical DBcAMP sodium salt workflows with tau pathology assays, neuronal metabolism, differentiation, and inflammation studies while emphasizing controls and interpretation limits.
-
7ACC2: A Causal Tool for Tumor Metabolism
2026-08-16
7ACC2 is a monocarboxylate transporter 1 inhibitor with an unusual dual impact on lactate uptake and mitochondrial pyruvate transport. This assay-first guide explains how to distinguish target engagement from downstream immunometabolic effects and design more informative cancer metabolism research workflows.
-
Dibutyryl-cAMP, Sodium Salt: Workflow Guide
2026-08-15
Dibutyryl-cAMP, sodium salt provides a practical way to raise intracellular cAMP and test PKA-centered responses without relying exclusively on receptor stimulation. This workflow guide connects DBcAMP sodium salt to neuronal remodeling, PKA activation assay design, inflammation modulation studies, and reproducible troubleshooting.
-
MHY1485: mTOR Activator Workflow Guide
2026-08-14
MHY1485 is a research-grade mTOR activator for dissecting autophagy, cell survival, and ovarian follicle biology. This practical guide connects pathway activation with assay design, controls, dosing strategy, and troubleshooting while contrasting MHY1485 with newer mTOR-directed metabolic research.
-
HIV-1 Signalling Remodels Nuclear Pores
2026-08-14
The reference study identifies nuclear import at the nuclear pore complex as a major barrier to HIV-1 infection of resting CD4+ T cells. It shows that virological synapse formation activates a CD4–LCK–CDK1 pathway that remodels nucleoporins and licenses viral nuclear entry without requiring cell-cycle progression.
-
FK866 Workflows for NAMPT Cancer Research
2026-08-13
Turn NAMPT biology into actionable experiments with FK866 (APO866), from NAD-depletion assays to biomarker-guided combination studies. This guide emphasizes exposure design, orthogonal readouts, and troubleshooting for hematologic cancer research and RAS/PI3K-mutant ovarian cancer models.
-
Tunable Human Intestinal Organoids: Study Insights
2026-08-13
A recent Nature Communications study describes a human small intestinal organoid system that maintains strong proliferation while expanding epithelial cell diversity under one culture condition. Its central innovation is the use of coordinated pathway modulation to strengthen stemness and then tune lineage allocation, offering a more scalable framework for intestinal development, disease modeling, and screening.
-
Dibutyryl-cAMP: A Rigorous Assay Lens
2026-08-12
Dibutyryl-cAMP, sodium salt is a cell-permeable cAMP analog for dissecting PKA-centered signaling without relying on upstream receptor activation. This article connects DBcAMP sodium salt assay design with the tau Ser356 findings of Taylor et al., emphasizing causal interpretation, controls, and model-specific limitations.
-
Cancer Drug Response Metrics: Arrest vs Death
2026-08-12
Hannah Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures in cancer drug studies. Its central contribution is a clearer framework for separating proliferative arrest from cell killing and for interpreting their different magnitudes and timing.
-
WSP-5: Imaging H2S in Diabetic Cardiomyopathy
2026-08-11
WSP-5, or Washington State Probe-5, gives translational researchers a way to move beyond bulk hydrogen sulfide measurements and visualize dynamic H2S signaling in disease-relevant cardiac models. This article connects the probe’s reaction-based fluorescence mechanism with evidence linking endogenous H2S deficiency to lipotoxicity and ER stress in diabetic cardiomyopathy, while outlining validation, workflow, and translational decision points.
-
KPT-330: Strategic Control of Nuclear Export
2026-08-11
KPT-330, also known as Selinexor, turns CRM1-dependent nuclear export into a translational research variable rather than a background process. This thought-leadership guide connects mechanism, model selection, combination strategy, protocol design, and biomarker thinking for researchers advancing precision oncology programs.
-
MMP-2-Responsive Liposomes for Sequential Immunotherapy
2026-08-10
The reference study develops an MMP-2-responsive, dual-targeting liposome that sequentially delivers the PD-1 pathway-blocking peptide AUNP-12 and the IDO inhibitor NLG919. By coupling tumor-cell recognition with enzyme-triggered peptide release and secondary targeting, the system aims to restore T-cell activity while remodeling the immunosuppressive microenvironment in metastatic breast cancer.
-
Sodium Oxamate for LDH-A and Lactylation Studies
2026-08-09
Sodium Oxamate provides a water-compatible way to perturb LDH-A activity, lactate production, and glycolytic adaptation in cancer models. This workflow connects metabolic measurements with lactylation, DNA-repair, and radiotherapy assays so researchers can distinguish pathway-specific effects from nonspecific toxicity.
-
RNAi Screen Maps SARS-CoV-2 Release Factors
2026-08-08
Kerr et al. developed a temporally resolved, druggable-genome RNA interference screen that captured host factors acting across SARS-CoV-2 replication, assembly, and release. The study identifies Rab11a-linked vesicular transport as a conserved proviral pathway and shows that CDK9 inhibitor-73 can block viral release, while also defining important limits for translating screening results into host-directed antiviral strategies.